We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $206B
1-Year Est. Return 31.61%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+0.08%
1 Year Est. Return
+31.61%
3 Year Est. Return
+91.73%
5 Year Est. Return
+103.23%
10 Year Est. Return
+394.96%
AUM
$56.3B
AUM Growth
+$6.14B
Cap. Flow
+$1.76B
Cap. Flow %
3.13%
Top 10 Hldgs %
15.08%
Holding
4,631
New
103
Increased
2,522
Reduced
1,306
Closed
116

Sector Composition

Rank Sector Weight
1 Technology 8.31%
2 Financials 6.96%
3 Consumer Discretionary 5.46%
4 Healthcare 4.97%
5 Industrials 4.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACTG icon
3801
Acacia Research
ACTG
$455M
$20.9K ﹤0.01%
7,808
-422
-5% -$1.18K
TTSH
3802
DELISTED
Tile Shop Holdings
TTSH
$20.9K ﹤0.01%
6,551
+1,901
+41% +$5.81K
GTES icon
3803
Gates Industrial Corporation Ltd.
GTES
$7.05B
$20.9K ﹤0.01%
2,074
+349
+20% +$3.42K
AMSC icon
3804
American Superconductor
AMSC
$1.56B
$20.8K ﹤0.01%
2,653
+1,897
+251% +$16.1K
FPRX
3805
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$20.8K ﹤0.01%
5,355
+1,646
+44% +$9.03K
ADPT icon
3806
Adaptive Biotechnologies
ADPT
$4.02B
$20.7K ﹤0.01%
+670
New +$27.3K
UNB icon
3807
Union Bankshares
UNB
$120M
$20.7K ﹤0.01%
656
+46
+8% +$1.46K
PMBC
3808
DELISTED
Pacific Mercantile Bancorp
PMBC
$20.6K ﹤0.01%
2,745
+39
+1% +$306
USDP
3809
DELISTED
USD PARTNERS LP
USDP
$20.6K ﹤0.01%
1,970
-1,408
-42% -$15.4K
BSAC icon
3810
Banco Santander Chile
BSAC
$16B
$20.6K ﹤0.01%
734
-8,267
-92% -$239K
MMLP icon
3811
Martin Midstream Partners
MMLP
$93.9M
$20.5K ﹤0.01%
4,514
-3,326
-42% -$17.1K
LEVL
3812
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
$20.4K ﹤0.01%
846
+5
+0.6% +$120
PAMT
3813
PAMT Corp
PAMT
$279M
$20.4K ﹤0.01%
1,380
+224
+19% +$3.09K
SU icon
3814
Suncor Energy
SU
$74.7B
$20.3K ﹤0.01%
644
-3,336
-84% -$100K
PDLB icon
3815
Ponce Financial Group
PDLB
$500M
$20.2K ﹤0.01%
2,003
+15
+0.8% +$153
TCRR
3816
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$20.2K ﹤0.01%
1,343
+1,265
+1,622% +$19.7K
RICK icon
3817
RCI Hospitality Holdings
RICK
$214M
$20.2K ﹤0.01%
975
+7
+0.7% +$120
CNCE
3818
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$20.1K ﹤0.01%
3,422
+1,049
+44% +$11.1K
NESR
3819
National Energy Services Reunited Corp
NESR
$3.51B
$20K ﹤0.01%
2,997
+1,854
+162% +$14.4K
ZYNE
3820
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$20K ﹤0.01%
2,647
+2,588
+4,386% +$29.2K
FFNW
3821
DELISTED
First Financial Northwest, Inc
FFNW
$19.9K ﹤0.01%
1,345
+38
+3% +$543
TMDX icon
3822
Transmedics
TMDX
$3.02B
$19.8K ﹤0.01%
834
+774
+1,290% +$18.6K
OPBK icon
3823
OP Bancorp
OPBK
$235M
$19.8K ﹤0.01%
2,023
+36
+2% +$344
SCWX
3824
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$19.7K ﹤0.01%
1,523
+41
+3% +$506
VSI
3825
DELISTED
Vitamin Shoppe Inc.
VSI
$19.6K ﹤0.01%
3,009
+240
+9% +$1.35K

Similar funds

BNP Paribas Financial Markets's Q3 2019 Portfolio in Review

As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $235M trimmed.

  • BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
  • BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
  • BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
  • BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
  • BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
  • BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
  • BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.